PVLAPalvella Therapeutics, Inc.

$154.47

Who owns PVLA

181 institutions reported holding PVLA for 2026Q1, together 101% of the company, more than the 140 a quarter earlier.

181

Institutions reporting a position · as of 2026Q1 · up from 140 the quarter before

Shares held by institutions
13.2M

Shares held by institutions · 101% of the company · long US equity positions only, as reported on Form 13F

Reported value
$1.64B

Reported value · at 2026-03-31 prices, not today's

Top 5 holders
36%

Top 5 holders · of the whole company, between five filers

Details
Reporting quarter2026-03-31
2026Q1
Quarters on record
6
New positions
60
Positions exited
24
Added to
64
Reduced
28
Top 10 holdersof the company
55%
Institutional ownership by quarter, 2024Q4 to 2026Q1
QuarterFilersSharesReported value
2026Q118113.2M$1.64B
2025Q41409.8M$1.02B
2025Q31008.5M$534M
2025Q2655.9M$133M
2025Q1415.1M$143M
2024Q4334.0M$48M
Largest reported holders, 2026Q1
HolderShares% of companyValue
SUVRETTA CAPITAL MANAGEMENT, LLC1.2M8.8%$144M
First Light Asset Management, LLC1.0M7.5%$122M
BVF INC/IL1.0M7.3%$120M
Frazier Life Sciences Management, L.P.0.9M6.7%$110M
BlackRock Inc.0.7M5.2%$86M
VANGUARD GROUP INC0.6M5.0%$81M
JENNISON ASSOCIATES LLC0.6M4.9%$80M
STATE STREET CORP0.5M3.5%$57M
FEDERATED INVESTORS INC /PA/0.4M3.3%$54M
PRICE T ROWE ASSOCIATES INC /MD/0.4M3.1%$50M

SEC Form 13F data sets (DERA bulk files). 13F is quarterly, filed up to 45 days late, and covers long US equity positions only, no shorts, no derivatives, nothing held below the reporting threshold.

reading the register…